Anti-MPZL2/ DFNB111/ EVA monoclonal antibody
Anti-MPZL2/ DFNB111/ EVA antibody for FACS & in-vivo assay
Go to MPZL2/MPZL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0825-Ab-1/ GM-Tg-hg-MP0825-Ab-2 | Anti-Human MPZL2 monoclonal antibody | Human |
GM-Tg-rg-MP0825-Ab-1/ GM-Tg-rg-MP0825-Ab-2 | Anti-Rat MPZL2 monoclonal antibody | Rat |
GM-Tg-mg-MP0825-Ab-1/ GM-Tg-mg-MP0825-Ab-2 | Anti-Mouse MPZL2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0825-Ab-1/ GM-Tg-cynog-MP0825-Ab-2 | Anti-Cynomolgus/ Rhesus macaque MPZL2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0825-Ab-1/ GM-Tg-felg-MP0825-Ab-2 | Anti-Feline MPZL2 monoclonal antibody | Feline |
GM-Tg-cang-MP0825-Ab-1/ GM-Tg-cang-MP0825-Ab-2 | Anti-Canine MPZL2 monoclonal antibody | Canine |
GM-Tg-bovg-MP0825-Ab-1/ GM-Tg-bovg-MP0825-Ab-2 | Anti-Bovine MPZL2 monoclonal antibody | Bovine |
GM-Tg-equg-MP0825-Ab-1/ GM-Tg-equg-MP0825-Ab-2 | Anti-Equine MPZL2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0825-Ab-1/ GM-Tg-hg-MP0825-Ab-2; GM-Tg-rg-MP0825-Ab-1/ GM-Tg-rg-MP0825-Ab-2; GM-Tg-mg-MP0825-Ab-1/ GM-Tg-mg-MP0825-Ab-2; GM-Tg-cynog-MP0825-Ab-1/ GM-Tg-cynog-MP0825-Ab-2; GM-Tg-felg-MP0825-Ab-1/ GM-Tg-felg-MP0825-Ab-2; GM-Tg-cang-MP0825-Ab-1/ GM-Tg-cang-MP0825-Ab-2; GM-Tg-bovg-MP0825-Ab-1/ GM-Tg-bovg-MP0825-Ab-2; GM-Tg-equg-MP0825-Ab-1/ GM-Tg-equg-MP0825-Ab-2 |
Products Name | Anti-MPZL2 monoclonal antibody |
Format | mab |
Target Name | MPZL2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-MPZL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species MPZL2/ DFNB111/ EVA VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP0825 |
Target Name | MPZL2 |
Gene ID | 10205,14012,300679,699330,489384,101089039,540423,100071229 |
Gene Symbol and Synonyms | DFNB111,EVA,EVA1,MPZL2 |
Uniprot Accession | O60487,Q5EAB0 |
Uniprot Entry Name | MPZL2_HUMAN,MPZL2_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000149573 |
Target Classification | N/A |
The target: MPZL2, gene name: MPZL2, also named as DFNB111, EVA, EVA1. Thymus development depends on a complex series of interactions between thymocytes and the stromal component of the organ. Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous to the myelin protein zero and, in thymus-derived epithelial cell lines, is poorly soluble in nonionic detergents, strongly suggesting an association to the cytoskeleton. Its capacity to mediate cell adhesion through a homophilic interaction and its selective regulation by T cell maturation might imply the participation of EVA in the earliest phases of thymus organogenesis. The protein bears a characteristic V-type domain and two potential N-glycosylation sites in the extracellular domain; a putative serine phosphorylation site for casein kinase 2 is also present in the cytoplasmic tail. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.